NSE ScannerChemicals · Chemicals: Specialty · NSE: YCCL · data 2026-11-01
Yasons Chemex Care Limited
In plain words
Price: 44.4% below its 52-week high of ₹13.5.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹97 cr |
| Net profit (last 12 months) | ₹1 cr |
| Sales growth, 3 years (yearly) | 38.1% |
| Profit growth, 3 years (yearly) | -35.1% |
At a glance
P/E 15.4, P/B 0.3, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 2.3%, ROCE -2.3%, operating margin -1.0%: how much profit it earns on the money it uses.
Debt/equity 0.32, Profit growth -35.1% and sales growth 38.1% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (2.3%).
- Thin operating margin (-1.0%).
- Profit fell 35.1% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Yasons Chemex Care Limited debt-free?
Its latest reported debt-to-equity ratio is 0.32.
What is Yasons Chemex Care Limited's P/E ratio?
About 15.4, based on the last 12 months' earnings and a price of ₹7.5 (data 2026-11-01).
What is the 52-week high and low of Yasons Chemex Care Limited?
The 52-week high is ₹13.5 and the 52-week low is ₹7.25.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Yasons Chemex Care Limited | ₹7.5 | ₹14 cr | 15.4 | 0.4 | 2.3% | -2.3% | 0.32 | -43.2% |
| Vineet Laboratories Ltd. | ₹37.92 | ₹71 cr | 15.1 | — | 3.7% | 15.6% | 0.99 | -4.4% |
| Unilex Colours & Chemicals Limited | ₹31.5 | ₹43 cr | 6.2 | — | 10.9% | 3.9% | 0.31 | -19.4% |
| Vadivarhe Speciality Chemicals Ltd. | ₹25.95 | ₹39 cr | — | — | — | — | — | +6.6% |
| Arunaya Organics Limited | ₹13.6 | ₹24 cr | 6.2 | 0.5 | 11.3% | 17% | 0.44 | -39.6% |
| Sati Poly Plast Ltd. | ₹38.7 | ₹19 cr | 5.6 | — | 19.3% | 26.9% | 0.62 | -46.2% |
Compare YCCL with VINEETLAB in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open YCCL in NSE Scanner →